These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23759657)

  • 1. Effects of pitavastin in Japanese patients with chronic heart failure.
    D'Imperio H; Sanchis J; Núñez E; Núñez J
    Circ J; 2013; 77(8):2204. PubMed ID: 23759657
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of pitavastatin in Japanese patients with chronic heart failure. Reply.
    Takano H
    Circ J; 2013; 77(8):2205. PubMed ID: 23759658
    [No Abstract]   [Full Text] [Related]  

  • 3. Statin therapy in chronic heart failure: frog prince or bare frog?
    Kihara Y
    Circ J; 2013; 77(4):895-7. PubMed ID: 23502989
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of pitavastatin in Japanese patients with chronic heart failure: the Pitavastatin Heart Failure Study (PEARL Study).
    Takano H; Mizuma H; Kuwabara Y; Sato Y; Shindo S; Kotooka N; Fujimatsu D; Kobayashi Y; Inoue T; Node K; Komuro I;
    Circ J; 2013; 77(4):917-25. PubMed ID: 23502990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate candidates for statin use in heart failure.
    Seo HS
    Korean J Intern Med; 2014 Nov; 29(6):730-4. PubMed ID: 25378970
    [No Abstract]   [Full Text] [Related]  

  • 6. Vesnarinone for heart failure.
    Swedberg K; Wedel H
    N Engl J Med; 1994 Jan; 330(1):64; author reply 65. PubMed ID: 8259151
    [No Abstract]   [Full Text] [Related]  

  • 7. Vesnarinone for heart failure.
    Neely D
    N Engl J Med; 1994 Jan; 330(1):65. PubMed ID: 8259152
    [No Abstract]   [Full Text] [Related]  

  • 8. Vesnarinone for heart failure.
    Schwartz A; Grupp I; Grupp G
    N Engl J Med; 1994 Jan; 330(1):65; author reply 66. PubMed ID: 8259153
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of a dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.
    LeJemtel TH
    Curr Cardiol Rep; 1999 May; 1(1):31. PubMed ID: 10980817
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive inotropic agents: a double-edged sword for chronic heart failure.
    Asanoi H; Inoue H
    Intern Med; 1996 Jan; 35(1):63-4. PubMed ID: 8652942
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe heart failure: balancing length and quality of life.
    Harv Heart Lett; 1999 Jun; 9(10):1-2. PubMed ID: 10233785
    [No Abstract]   [Full Text] [Related]  

  • 12. The search for the ideal positive inotropic agent.
    Packer M
    N Engl J Med; 1993 Jul; 329(3):201-2. PubMed ID: 8515793
    [No Abstract]   [Full Text] [Related]  

  • 13. [Usefulness of OPC-8212, an inotropic agent, in patients with chronic congestive heart failure--a multiple dose evaluation on its effect and arrhythmogenesis].
    Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
    Kokyu To Junkan; 1988 Oct; 36(10):1125-31. PubMed ID: 3247528
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences in an author's conflict of interest disclosures.
    Braunwald E
    JAMA; 2012 Feb; 307(6):561; discussion 561. PubMed ID: 22318272
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study.
    Lee HY; Cho HJ; Kim HY; Jeon HK; Shin JH; Kang SM; Baek SH
    Korean J Intern Med; 2014 Nov; 29(6):754-63. PubMed ID: 25378974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotropic therapy for heart failure.
    Stevenson LW
    N Engl J Med; 1998 Dec; 339(25):1848-50. PubMed ID: 9854124
    [No Abstract]   [Full Text] [Related]  

  • 17. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.
    Cohn JN; Goldstein SO; Greenberg BH; Lorell BH; Bourge RC; Jaski BE; Gottlieb SO; McGrew F; DeMets DL; White BG
    N Engl J Med; 1998 Dec; 339(25):1810-6. PubMed ID: 9854116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Statins Modify the Wound Healing Process After Myocardial Infarction?
    Hasegawa H
    Int Heart J; 2017 Aug; 58(4):472-474. PubMed ID: 28717118
    [No Abstract]   [Full Text] [Related]  

  • 19. Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study.
    Ashton E; Windebank E; Skiba M; Reid C; Schneider H; Rosenfeldt F; Tonkin A; Krum H
    Int J Cardiol; 2011 Feb; 146(3):404-7. PubMed ID: 20085851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and problems of cardiotonic agents viewed from physiopathology of chronic congestive heart failure].
    Asanoi H; Inoue H
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1465-9. PubMed ID: 8537751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.